PUBLISHER: The Business Research Company | PRODUCT CODE: 1668744
PUBLISHER: The Business Research Company | PRODUCT CODE: 1668744
Alcoholic Hepatitis Treatment Global Market Report 2025
Alcoholic hepatitis treatment involves interventions aimed at promoting abstinence from alcohol and addressing the symptoms of liver damage. The therapeutic approach to alcoholic hepatitis focuses on the cessation of alcohol consumption and the administration of medications to alleviate liver-related symptoms.
The primary modalities of treatment for alcoholic hepatitis include pharmaceutical interventions and stem cell therapy. Pharmaceutical treatment entails the use of medications, excluding food, to prevent, detect, treat, or alleviate the symptoms of diseases or abnormal conditions. Drug classes such as corticosteroids, hemorheologic agents, monoclonal antibodies, anabolic steroids, and others are administered through oral and injectable routes. These treatments are typically provided by healthcare facilities, clinics, and private treatment centers.
The alcoholic hepatitis treatment market research report is one of a series of new reports from The Business Research Company that provides alcoholic hepatitis treatment market statistics, including alcoholic hepatitis treatment industry global market size, regional shares, competitors with an alcoholic hepatitis treatment market share, detailed alcoholic hepatitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alcoholic hepatitis treatment industry. This alcoholic hepatitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The alcoholic hepatitis treatment market size has grown strongly in recent years. It will grow from $3.2 billion in 2024 to $3.44 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to high prevalence of alcohol abuse, increased awareness and diagnostics, government initiatives on alcoholism, increased healthcare expenditure, public health campaigns
The alcoholic hepatitis treatment market size is expected to see strong growth in the next few years. It will grow to $4.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging therapies and drug pipeline, precision medicine approaches, growing understanding of disease pathogenesis, increasing focus on liver health, public health policies addressing alcohol abuse. Major trends in the forecast period include personalized medicine approaches, liver transplantation trends, telemedicine and remote monitoring, collaborative research initiatives, innovative drug solutions.
The rising incidence of liver diseases related to alcohol consumption is anticipated to drive the growth of the alcoholic hepatitis treatment market in the future. Alcoholic liver disease results from damage to the liver's functions, which include filtering blood and producing bile for digestion. Alcoholic hepatitis treatment aims to address liver inflammation in some patients with this condition. Those with severe alcoholic hepatitis may require hospitalization for therapy. For example, in April 2024, data published by the Office for Health Improvement and Disparities, a UK government unit, revealed that there were 10,593 premature deaths from liver disease in 2022, including 6,664 males and 3,929 females. Additionally, the financial year ending in 2023 recorded 85,665 hospital admissions for liver disease in England, translating to a rate of 155.2 per 100,000 population, with 27,085 admissions specifically for alcoholic liver disease, which corresponds to a rate of 49.4 per 100,000 population. Therefore, the rising prevalence of alcohol-related liver diseases is propelling the growth of the alcoholic hepatitis treatment market.
The increasing emphasis on personalized medicine is expected to further boost the growth of the alcoholic hepatitis treatment market. Personalized medicine is a groundbreaking approach to medical treatment and healthcare that considers individual variations in patients' genes, environments, and lifestyles. This approach enables customized treatment plans, identification of susceptibility factors, optimization of medication selection, tailored therapies, individualized risk assessment, and a reduction in adverse effects, ultimately enhancing patient engagement and compliance with treatment plans. For instance, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021, with 12 new approvals in 2022, maintaining a consistent share of at least 25% of new drug approvals over the past eight years-a significant rise from under 10% a decade ago. Therefore, the growing focus on personalized medicine is driving the growth of the alcoholic hepatitis treatment market.
Product innovation stands as a prominent and increasingly adopted trend within the alcoholic hepatitis treatment market. Companies engaged in this sector are placing significant emphasis on pioneering new products to maintain their competitive edge. An illustrative example is the July 2022 release by Roche Holding AG of the Elecsys HCV Duo, a groundbreaking dual antibody and antigen diagnostic test for hepatitis C virus (HCV). This innovative test enables independent and simultaneous detection of HCV antigen and antibody status using a single human plasma or serum sample. It aids in identifying patients in recovery or exhibiting chronic infection symptoms that might lead to conditions such as liver cancer or early-stage infections. The early manifestation of HCV's core antigen during infection, utilized as an indicator of ongoing viral replication, enables physicians to diagnose active HCV at an earlier stage compared to using solely antibody assays, enhancing diagnostic capabilities.
Prominent entities in the alcoholic hepatitis treatment market are channeling their efforts towards product development, specifically focusing on immunoassays, as a strategic driver for revenue generation. Immunoassays represent a type of biochemical testing method leveraging antibodies' specific binding to antigens to detect and quantify the presence or concentration of a target molecule (analyte) in a sample. For instance, in November 2023, F. Hoffmann-La Roche Ltd. unveiled Elecsys HBeAg quant, an immunoassay designed to measure hepatitis B e antigen (HBeAg) levels in human serum and plasma in both qualitative and quantitative formats. It serves as a predictive tool for chronic active hepatitis and an early indicator of acute hepatitis B infection. This test aids in diagnosing and monitoring individuals with hepatitis B virus infection when complemented with supplementary laboratory findings and clinical data. The Elecsys HBeAg quant, compatible with Roche's Cobas e analyzers, is intended for use with samples from patients with known positive results as well as those with an undetermined HBeAg status.
In October 2022, the France-based biotechnology company Genfit completed the acquisition of Versantis AG for an undisclosed amount. This strategic move enhances GENFIT's leadership position in acute-on-chronic liver failure (ACLF) and significantly broadens its pipeline. The acquisition brings valuable assets to GENFIT's portfolio, including VS-01-ACLF, a Phase 2-ready program based on first-in-class scavenging liposomes technology, VS-01-UCD, a pediatric program targeting urea cycle disorder (UCD), and VS-02-HE, an early-stage program focusing on hepatic encephalopathy (HE). Versantis AG, based in Switzerland, is a biotech company specializing in the development of therapeutics for hepatitis and alcohol-related liver diseases.
Major companies operating in the alcoholic hepatitis treatment market include AbbVie Inc., Gilead Sciences Inc., Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, F. Hoffmann-La Roche Ltd, Sanofi S.A., Novartis AG, Amgen Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim International GmbH, Mallinckrodt Pharmaceuticals, Intercept Pharmaceuticals Inc., Madrigal Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., DURECT Corporation, Viking Therapeutics Inc., CymaBay Therapeutics Inc., Genfit SA, BioVie Inc., Akero Therapeutics Inc., Zydus Cadila, Dr. Reddy's Laboratories Ltd.
North America was the largest region in the alcoholic hepatitis treatment market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the alcoholic hepatitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The alcoholic hepatitis treatment market consists of revenues earned by entities by providing infection surveillance, ulcer prophylaxis, and liver transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The alcoholic hepatitis treatment market also includes sales of anti-inflammatory medication such as steroids, pentoxifylline, and glucocorticoids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Alcoholic Hepatitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on alcoholic hepatitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for alcoholic hepatitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alcoholic hepatitis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment: Drug Treatment; Stem Cell Therapy
- 2) By Drug Class: Corticosteroids; Hemorheologic Agents; Monoclonal Antibodies; Anabolic Steroids; Other Drug Classes
- 3) By Route Of Administration: Oral; Injectable
- 4) By Application: Hospital; Clinic; Private Treatment Center
- Subsegments:
- 1) By Drug Treatment: Corticosteroids; Pentoxifylline; Other Immunosuppressants
- 2) By Stem Cell Therapy: Autologous Stem Cell Therapy; Allogeneic Stem Cell Therapy
- Companies Mentioned: AbbVie Inc.; Gilead Sciences Inc.; Bristol-Myers Squibb Company; Pfizer Inc.; Merck & Co. Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Alcoholic Hepatitis Treatment Market Characteristics
3. Alcoholic Hepatitis Treatment Market Trends And Strategies
4. Alcoholic Hepatitis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Alcoholic Hepatitis Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Alcoholic Hepatitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Alcoholic Hepatitis Treatment Market Growth Rate Analysis
- 5.4. Global Alcoholic Hepatitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Alcoholic Hepatitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Alcoholic Hepatitis Treatment Total Addressable Market (TAM)
6. Alcoholic Hepatitis Treatment Market Segmentation
- 6.1. Global Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Treatment
- Stem Cell Therapy
- 6.2. Global Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Hemorheologic Agents
- Monoclonal Antibodies
- Anabolic Steroids
- Other Drug Classes
- 6.3. Global Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- 6.4. Global Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Clinic
- Private Treatment Center
- 6.5. Global Alcoholic Hepatitis Treatment Market, Sub-Segmentation Of Drug Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Pentoxifylline
- Other Immunosuppressants
- 6.6. Global Alcoholic Hepatitis Treatment Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Therapy
7. Alcoholic Hepatitis Treatment Market Regional And Country Analysis
- 7.1. Global Alcoholic Hepatitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Alcoholic Hepatitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Alcoholic Hepatitis Treatment Market
- 8.1. Asia-Pacific Alcoholic Hepatitis Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Alcoholic Hepatitis Treatment Market
- 9.1. China Alcoholic Hepatitis Treatment Market Overview
- 9.2. China Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Alcoholic Hepatitis Treatment Market
- 10.1. India Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Alcoholic Hepatitis Treatment Market
- 11.1. Japan Alcoholic Hepatitis Treatment Market Overview
- 11.2. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Alcoholic Hepatitis Treatment Market
- 12.1. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Alcoholic Hepatitis Treatment Market
- 13.1. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Alcoholic Hepatitis Treatment Market
- 14.1. South Korea Alcoholic Hepatitis Treatment Market Overview
- 14.2. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Alcoholic Hepatitis Treatment Market
- 15.1. Western Europe Alcoholic Hepatitis Treatment Market Overview
- 15.2. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Alcoholic Hepatitis Treatment Market
- 16.1. UK Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Alcoholic Hepatitis Treatment Market
- 17.1. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Alcoholic Hepatitis Treatment Market
- 18.1. France Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Alcoholic Hepatitis Treatment Market
- 19.1. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Alcoholic Hepatitis Treatment Market
- 20.1. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Alcoholic Hepatitis Treatment Market
- 21.1. Eastern Europe Alcoholic Hepatitis Treatment Market Overview
- 21.2. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Alcoholic Hepatitis Treatment Market
- 22.1. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Alcoholic Hepatitis Treatment Market
- 23.1. North America Alcoholic Hepatitis Treatment Market Overview
- 23.2. North America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Alcoholic Hepatitis Treatment Market
- 24.1. USA Alcoholic Hepatitis Treatment Market Overview
- 24.2. USA Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Alcoholic Hepatitis Treatment Market
- 25.1. Canada Alcoholic Hepatitis Treatment Market Overview
- 25.2. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Alcoholic Hepatitis Treatment Market
- 26.1. South America Alcoholic Hepatitis Treatment Market Overview
- 26.2. South America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Alcoholic Hepatitis Treatment Market
- 27.1. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Alcoholic Hepatitis Treatment Market
- 28.1. Middle East Alcoholic Hepatitis Treatment Market Overview
- 28.2. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Alcoholic Hepatitis Treatment Market
- 29.1. Africa Alcoholic Hepatitis Treatment Market Overview
- 29.2. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Alcoholic Hepatitis Treatment Market Competitive Landscape And Company Profiles
- 30.1. Alcoholic Hepatitis Treatment Market Competitive Landscape
- 30.2. Alcoholic Hepatitis Treatment Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Alcoholic Hepatitis Treatment Market Other Major And Innovative Companies
- 31.1. Johnson & Johnson
- 31.2. GlaxoSmithKline plc
- 31.3. AstraZeneca plc
- 31.4. F. Hoffmann-La Roche Ltd
- 31.5. Sanofi S.A.
- 31.6. Novartis AG
- 31.7. Amgen Inc.
- 31.8. Eli Lilly and Company
- 31.9. Takeda Pharmaceutical Company Limited
- 31.10. Bayer AG
- 31.11. Boehringer Ingelheim International GmbH
- 31.12. Mallinckrodt Pharmaceuticals
- 31.13. Intercept Pharmaceuticals Inc.
- 31.14. Madrigal Pharmaceuticals, Inc.
- 31.15. Conatus Pharmaceuticals Inc.
32. Global Alcoholic Hepatitis Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Alcoholic Hepatitis Treatment Market
34. Recent Developments In The Alcoholic Hepatitis Treatment Market
35. Alcoholic Hepatitis Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Alcoholic Hepatitis Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Alcoholic Hepatitis Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Alcoholic Hepatitis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
